BioSpace News Archive

BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Japanese Patent Office has issued the Company a patent related to its metabolic ThermoStem® Program.

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will feature its recently expanded Extremities portfolio at the American Academy of Orthopaedic Surgeons 2021 Annual Meeting being held in San Diego, CA.

Targeted Oncology™, a leading multimedia resource in the field of oncology, announced the launch of its new clinical trial database.

Endevica Bio, a company developing best-in-class peptide drug candidates with better safety and efficacy properties, presented new data from a recent preclinical study with its lead compound TCMCB07 at the 6th Cancer Cachexia Conference in August 27-29, 2021.

US WorldMeds, a Kentucky-based specialty pharmaceutical company, announced Walgreens will stock LUCEMYRA (lofexidine) tablets in Walgreens pharmacies across the U.S., effective September 1.

Transaction Data Systems (TDS), the leader in pharmacy software solutions, today announced it will be hiring of 150 new client and innovation focused roles over the next 12 months, following the appointment of four new executives hired to lead the investment strategy.

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), announced today that its clinical trial product, CypCaps™, remains stable and active at 18 months after completing the 18-month timepoint of ongoing product stability testing required by the U.S. Food and Drug Administration (FDA).

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced findings of a new study first presented at the annual meeting of the International Society for the Advancement of Spinal Surgery (ISASS) (May 13-15, 2021, Miami, FL)

Treatment for Critically Ill COVID Patients Begins 1 st Randomized Clinical Trial

Verily, an Alphabet company, today announced that its previously announced acquisition of SignalPath, a privately held company that makes clinical research software based in Raleigh, has successfully closed.